coteauBeta Get App

XRTX

XORTX Therapeutics Inc.
$0.96
-5.35% Oct 20 close
Healthcare CompareTechnicals
-75%-52%-29%-6%+17%Oct 2025Oct 2026Apr 2026
XRTXSPY
1W
-43.1%
1M
-50.2%
3M
-53.1%
6M
-64.5%
YTD
-66.0%
1Y
-74.5%

Live chart

Loading live chart…

What they do

Healthcare · Biotechnology

For information only · Important disclosures

Grades vs sector

No sector grades for XRTX yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
GlobeNewswire · Oct 08
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
GlobeNewswire · Sep 18
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
GlobeNewswire · Sep 10
XORTX Re-Engages Investor Relations Program
GlobeNewswire · Sep 08
XORTX Announces Termination and Postponement of Investor Relations Program
GlobeNewswire · Aug 28

Key stats

Market value$1.7M
P/E (next 12 months, estimated)1.2
52-week range$0.92 – $4.00
Dividend yieldNo dividend
Valuation and fundamentals

Valuation & fundamentals

No US-GAAP 10-K/10-Q financials in SEC data (foreign filers report on Form 20-F, often under IFRS).

Earnings

Next report: 2026-11-12 · before open
23-0523-0824-0424-0524-0825-0325-1126-02-11.250.00
EstimateActual (beat)Actual (miss)
ReportEPS estActualSurprise
2026-02-26-1.58-0.45+71.5%
2025-11-14-1.58-1.02+35.2%
2025-03-25-2.08-1.17+43.4%
2024-08-14-4.61-3.44+25.5%
2024-05-15-4.21-2.96+29.6%
2024-04-02-4.07-3.18+22.0%
2023-08-13-11.25-4.23+62.4%
2023-05-14-10.35-4.77+53.9%

Quarterly revenue

QuarterRevenueYoY
2026-06-30$0–
2026-03-31$0–
2025-12-31$0–
2025-09-30$0–
2025-06-30$0–

Stats refreshed 2026-10-21 01:37:36 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

Beta 0.9 · Oct 21, 2026